Title : [Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015].

Pub. Date : 2015

PMID : 26489498






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rituximab, the most widely used anti-CD20 antibody in routine clinical practice, led not only to improvement of progression-free survival, but also to improvement of overall survival in previously untreated patients with good performance status in combination with fludarabine and cyclophosphamide. Cyclophosphamide keratin 20 Homo sapiens